In-treatment (n = 6871) | After treatment (n = 1650) | |||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Treatment period | ||||
1997–1999 (reference) | ||||
2000–2002 | 0.88 (0.67–1.18) | 0.398 | 0.93 (0.34–2.57) | 0.889 |
2003–2005 | 0.71 (0.52–0.97) | 0.33 | 0,56 (0.20–1.56) | 0.266 |
2006–2009 | 0.59 (0.39–0.98) | 0.11 | 0.43 (0.51–1.20) | 0.106 |
Gender | ||||
Men (reference) | ||||
Female | 0.95 (0.76–2.20) | 0.68 | 0.73 (0.54–1.00) | 0.046 |
Age Treatment start | 1.07 (1.06–1.09) | < 0,001 | 0.99 (0.97–1.01) | 0.577 |